Emerging therapies for the treatment of rare pediatric bone disorders
In recent years, new therapies for the treatment of rare pediatric bone disorders have emerged, guided by an increasing understanding of the genetic and molecular etiology of these diseases. Herein, we review three such disorders, impacted by debilitating deficits in bone mineralization or cartilage...
Main Authors: | Kathryn M. Thrailkill, Evangelia Kalaitzoglou, John L. Fowlkes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.1012816/full |
Similar Items
-
Effect of asfotase alfa in the treatment of hypophosphatasia- A systematic review
by: N Jaswanthi, et al.
Published: (2023-01-01) -
Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasia
by: Olivia Sarah Strandbech, et al.
Published: (2021-05-01) -
The results of the survey among the parents of patients with achondroplasia on the role of vosoritide therapy
by: Dmitry A. Popkov, et al.
Published: (2021-08-01) -
Impact of discontinuing 5 years of enzyme replacement treatment in a cohort of 6 adults with hypophosphatasia: A case series
by: Cheryl Rockman-Greenberg, et al.
Published: (2022-12-01) -
Asfotase Alfa Treatment in a 2-year-old Girl with Childhood Hypophosphatasia
by: Gönül Çatlı, et al.
Published: (2022-06-01)